GREVE: Genomic Recurrent Event ViEwer to assist the identification of patterns across individual cancer samples.

SUMMARY: GREVE has been developed to assist with the identification of recurrent genomic aberrations across cancer samples. The exact characterization of such aberrations remains a challenge despite the availability of increasing amount of data, from SNParray to next-generation sequencing. Furthermo...

Full description

Bibliographic Details
Main Authors: Cazier, J, Holmes, C, Broxholme, J
Format: Journal article
Language:English
Published: 2012
_version_ 1797085290771251200
author Cazier, J
Holmes, C
Broxholme, J
author_facet Cazier, J
Holmes, C
Broxholme, J
author_sort Cazier, J
collection OXFORD
description SUMMARY: GREVE has been developed to assist with the identification of recurrent genomic aberrations across cancer samples. The exact characterization of such aberrations remains a challenge despite the availability of increasing amount of data, from SNParray to next-generation sequencing. Furthermore, genomic aberrations in cancer are especially difficult to handle because they are, by nature, unique to the patients. However, their recurrence in specific regions of the genome has been shown to reflect their relevance in the development of tumors. GREVE makes use of previously characterized events to identify such regions and focus any further analysis. AVAILABILITY: GREVE is available through a web interface and open-source application (http://www.well.ox.ac.uk/GREVE).
first_indexed 2024-03-07T02:06:50Z
format Journal article
id oxford-uuid:9f498348-f1ec-484d-bc3d-8449211805f8
institution University of Oxford
language English
last_indexed 2024-03-07T02:06:50Z
publishDate 2012
record_format dspace
spelling oxford-uuid:9f498348-f1ec-484d-bc3d-8449211805f82022-03-27T00:56:25ZGREVE: Genomic Recurrent Event ViEwer to assist the identification of patterns across individual cancer samples.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:9f498348-f1ec-484d-bc3d-8449211805f8EnglishSymplectic Elements at Oxford2012Cazier, JHolmes, CBroxholme, JSUMMARY: GREVE has been developed to assist with the identification of recurrent genomic aberrations across cancer samples. The exact characterization of such aberrations remains a challenge despite the availability of increasing amount of data, from SNParray to next-generation sequencing. Furthermore, genomic aberrations in cancer are especially difficult to handle because they are, by nature, unique to the patients. However, their recurrence in specific regions of the genome has been shown to reflect their relevance in the development of tumors. GREVE makes use of previously characterized events to identify such regions and focus any further analysis. AVAILABILITY: GREVE is available through a web interface and open-source application (http://www.well.ox.ac.uk/GREVE).
spellingShingle Cazier, J
Holmes, C
Broxholme, J
GREVE: Genomic Recurrent Event ViEwer to assist the identification of patterns across individual cancer samples.
title GREVE: Genomic Recurrent Event ViEwer to assist the identification of patterns across individual cancer samples.
title_full GREVE: Genomic Recurrent Event ViEwer to assist the identification of patterns across individual cancer samples.
title_fullStr GREVE: Genomic Recurrent Event ViEwer to assist the identification of patterns across individual cancer samples.
title_full_unstemmed GREVE: Genomic Recurrent Event ViEwer to assist the identification of patterns across individual cancer samples.
title_short GREVE: Genomic Recurrent Event ViEwer to assist the identification of patterns across individual cancer samples.
title_sort greve genomic recurrent event viewer to assist the identification of patterns across individual cancer samples
work_keys_str_mv AT cazierj grevegenomicrecurrenteventviewertoassisttheidentificationofpatternsacrossindividualcancersamples
AT holmesc grevegenomicrecurrenteventviewertoassisttheidentificationofpatternsacrossindividualcancersamples
AT broxholmej grevegenomicrecurrenteventviewertoassisttheidentificationofpatternsacrossindividualcancersamples